Patent details

Basic Information

Publication number:

EP1218009

PCT Application Number:

PCT/GB/2000/003598

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP009608555

PCT Publication Number:

WO/2001/021179

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

QUETIAPINE GRANULES

French Title of Invention:

GRANULES CONTENANT DE LA QUETIAPINE

German Title of Invention:

QUETIAPIN GRANULAT

SPC Number:

Dates

Filing date:

18/09/2000

Grant date:

02/02/2005

EP Publication Date:

02/02/2005

PCT Publication Date:

29/03/2001

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

03/07/2002

EP B1 Publication Date:

02/02/2005

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

18/09/2016

Expiration date:

18/09/2020

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

18/09/2000

 

 

Name:

AstraZeneca AB

Address:

-, 151 85 Södertälje, Sweden (SE)

Agent

Name:

FRIEDERICH PIERRE

From:

24/03/2005

Address:

ROUTE D'ARLON 261, 8002, STRASSEN, Luxembourg (LU)

To:

Inventor

Name:

BROWN Daniel, Boyd

Address:

United States (US)

Priority

Priority Number:

9922271

Priority Date:

21/09/1999

Priority Country:

United Kingdom (GB)

Classification

IPC classification:

A61K 9/00; A61K 9/16; A61K 31/55; A61P 25/18;

Publication

European Patent Bulletin

Issue number:

201907

Publication date:

13/02/2019

Description:

International Patent Classification Changed

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

14/09/2015

Last Annual Fee Paid Number:

16

Last Annual Fee Paid Amount:

230 Euro

Payer:

MARKS & CLERK LLP

Filing date	Document type	Number of pages